Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Foresite Capital Management V, LLC. Insider active across 4 companies, notably Pardes Biosciences, INC.. In total, 13 filings have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €6.3m. History available since 1 December 2022. The latest transaction was filed on 10 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Foresite Capital Management V, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
637,420 shares@ US$0.8532.8% of flowCommon StockSEC:0001213900-22-077637:0
Canonical exit: 1 Mar 2023 (T+90)
13 of 13 declarations
About Foresite Capital Management V, LLC
Foresite Capital Management V, LLC is a declarant linked to Latigo Biotherapeutics, Inc., Theseus Pharmaceuticals, Inc., Pardes Biosciences, INC. and ALUMIS INC. It has filed 13 filings in total, and across the 13 sampled filings, buys amount to EUR 6324436 between 2022-12-05 and 2026-08-10, with a transaction nature of C.